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Background. The somatosensory temporal discrimination threshold (STDT) is defined as the shortest interval at which an
individual recognizes two stimuli as asynchronous. Some evidence suggests that STDT depends on cortical inhibitory
interneurons in the basal ganglia and in primary somatosensory cortex. Several studies have reported that the STDT in patients
with dystonia is abnormal. No longitudinal studies have yet investigated whether STDT values in different forms of focal
dystonia change during the course of the disease. Methods. We designed a follow-up study on 25 patients with dystonia (15 with
blepharospasm and 10 with cervical dystonia) who were tested twice: upon enrolment and 8 years later. STDT values from
dystonic patients at the baseline were also compared with those from a group of 30 age-matched healthy subjects. Results. Our
findings show that the abnormally high STDT values observed in patients with focal dystonia remained unchanged at the 8-year
follow-up assessment whereas disease severity worsened. Conclusions. Our observation that STDT abnormalities in dystonia
remain unmodified during the course of the disease suggests that the altered activity of inhibitory interneurons—either at
cortical or at subcortical level—responsible for the increased STDT does not deteriorate as the disease progresses.
1. Introduction
Dystonia is a movement disorder characterized by sustained
or intermittent muscle contractions that cause abnormal,
often repetitive, movements and postures [1, 2]. Depending
on its distribution in the body, dystonia is classified under
generalized, segmental, and focal forms, with the last being
the most common in adult patients [1, 2]. Although the
underlying pathophysiological mechanisms of dystonia are
still debated, a large body of evidence suggests that reduced
inhibitory activity at various levels of the central nervous sys-
tem and altered cortical plasticity are involved [3–8].
The somatosensory temporal discrimination threshold
(STDT) is the shortest interval at which an individual recog-
nizes a pair of stimuli as separated in time [9, 10], and previ-
ous studies have shown that the STDT depends on the
integrated activity of an extensive network that includes
sensory cortex and basal ganglia [11–14]. Consistent findings
have also shown that the STDT in patients with focal and
generalized dystonia is abnormal [15–18].
Since the STDT is abnormally increased in both
affected [16, 17, 19, 20] and unaffected body regions [21] in
patients with dystonia as well as in patients’ unaffected
relatives [16, 17, 21], the STDT has been proposed as a
mediational endophenotypic feature of dystonia [14].
In healthy subjects, inhibitory interneurons in primary
somatosensory cortex play a role in STDT by sharpening
and focusing sensory information in the temporal domain
[13, 22]. Several authors have suggested that an abnormal
activity of inhibitory interneurons in S1 is likely to be respon-
sible for the increased STDT values in dystonia [23–25]. No
longitudinal studies have yet investigated whether STDT
values in focal dystonia change during the course of the dis-
ease. A better understanding of this issue may shed light on
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the pathophysiological mechanisms underlying STDT
abnormality. To this end, we designed a follow-up study to
investigate whether the STDT values of patients with differ-
ent forms of focal dystonia change during the course of the
disease. For this purpose, we tested a group of patients with
focal dystonias (blepharospasm and cervical dystonia) twice:
the first time upon enrolment and the second time 8 years
later. STDT values from dystonic patients at baseline were
compared with those from a group of age-matched healthy
subjects. We also investigated possible correlations between
changes in STDT values and changes in disease severity.
2. Methods
Twenty-five patients with primary focal dystonia (15 patients
with blepharospasm and 10 patients with cervical dystonia)
(Table 1) were enrolled in the study from the outpatient
clinic of movement disorders, Department of Neurology
and Psychiatry, Sapienza, University of Rome. Thirty age-
matched healthy subjects (age: 59± 13 years) were enrolled
as controls. All the dystonic patients were studied 4 months
after the last botulinum toxin injection. Information regard-
ing the patients’ demographic features, medical and family
histories, disease course, and treatment were collected during
a face-to-face interview (Table 1). Since STDT testing
assesses a psychometric function, it yields reliable data only
in the absence of cognitive or overt psychiatric conditions.
Exclusion criteria for this study were therefore a medical his-
tory of psychiatric conditions and those patients with a FAB
score lower than 15. To rate disease severity, we used a three-
point clinical scale (1 =mild, 3 = severe) to assess the clinical
severity for blepharospasm [15, 19] and the TorontoWestern
Spasmodic Torticollis Rating Scale (TWSTRS) [26] for cervi-
cal dystonia. The study was approved by the local institu-
tional review board and performed in accordance with the
Declaration of Helsinki.
The STDT was investigated by delivering paired stimuli
starting with an interstimulus interval of 0ms (simultaneous
pair), and progressively increasing the interstimulus interval
in 10ms steps, according to the experimental procedures
used in the previous studies [15, 19, 27–29]. Paired tactile
stimuli consisted of square wave electrical pulses delivered
with a constant current stimulator (Digitimer DS7AH)
through surface skin electrodes with the anode located
0.5 cm distally to the cathode. Since the body part affected
by dystonia in blepharospasm and cervical dystonia is differ-
ent, we tested STDT values on the volar surface of the right
index finger in order to obtain a between-group comparison
Table 1
Pts Gender
Age at the
enrolment (years)
Duration at the
enrolment (years)
Type of dystonia
Disease severity∗
at baseline
Disease severity
8-year FU
1 F 73 7 BPS 3 3
2 F 58 8 BPS 2 3
3 F 74 17 BPS 3 3
4 M 64 2 BPS 3 3
5 F 76 30 BPS 1 2
6 F 66 10 BPS 3 3
7 F 73 20 BPS 1 3
8 M 73 11 BPS 2 3
9 M 58 6 BPS 3 3
10 M 72 9 BPS 3 3
11 M 73 22 BPS 2 2
12 M 50 3 BPS 2 3
13 F 73 12 BPS 2 2
14 F 82 25 BPS 1 3
15 F 51 23 BPS 2 3
16 F 51 2 CD 11 23
17 F 49 12 CD 18 16
18 F 66 12 CD 8 17
19 F 73 2 CD 12 15
20 F 44 21 CD 16 20
21 F 51 2 CD 10 29
22 F 53 7 CD 9 19
23 M 35 12 CD 12 16
24 M 42 12 CD 15 17
25 F 50 15 CD 12 16
BSP: blepharospasm; CD: cervical dystonia; ∗disease severity in BSP patients represents scores on a three-point scale whereas in patients with CD it represents
scores at the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS); FU: follow-up.
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of STDT values on the same body part. The stimulation
intensity was defined for each subject by delivering a series
of stimuli at an intensity that increased in 0.5mA steps
starting from 2mA; the intensity used for the STDT was
the minimum intensity perceived by the subject in 10 of 10
consecutive stimuli. The first of three consecutive interstim-
ulus intervals at which participants recognized the stimuli
as temporally separated was considered the STDT. The
STDT was defined as the average of three STDT values and
was entered in the data analysis. The STDT was tested and
measured by neurophysiologists who were blinded to the
clinical assessment both at the baseline and 8 years later.
2.1. Statistical Analysis. We first compared STDT values in
dystonic patients upon enrolment with those from a group
of age-matched healthy controls using an unpaired sample
t-test. We then ran a paired sample t-test to evaluate changes
in clinical scores and STDT values obtained upon enrolment
and at the 8-year follow-up assessment in patients with
dystonia. To evaluate whether STDT values changed to a
different extent in patients with blepharospasm and cervical
dystonia across the two assessments, we also ran a between-
group repeated measures ANOVA with factor GROUP
(blepharospasm versus cervical dystonia) and TIME (two
levels: enrolment and 8-year FU). Spearman’s correlation
coefficient was used to evaluate any relationships between
clinical and neurophysiological variables.
3. Results
The unpaired sample t-test used to compare STDT values in
patients upon enrolment, and healthy subjects showed that
STDT values in dystonic patients were higher than those in
healthy subjects (p < 0 001) (Figure 1).
When we compared the clinical severity scores at the first
evaluation with those at the 8-year follow-up evaluation, the
paired sample t-test revealed a significant increase in disease
severity scores in patients (blepharospasm: p = 0 007; cervical
dystonia: p = 0 008) (Table 1). Only 1 patient with cervical
dystonia and 7 patients with blepharospasm had spread to
other body parts (upper limb in the patient with cervical dys-
tonia and oromandibular dystonia in those with blepharo-
spasm) at the follow-up assessment.
The paired sample t-test performed to investigate any
changes in STDT values in patients between the baseline
evaluation and the 8-year follow-up evaluation showed that
STDT values remained unchanged (baseline: 106± 25ms
versus 8-year follow-up: 107± 32ms; p = 0 83) (Figure 1).
Paired sample t-test to evaluate whether STDT values from
the 8 patients who had clinical signs of spread changed at
follow-up showed no significant changes (p = 0 85).
Repeated measures ANOVA to evaluate whether STDT
changed differently in patients with blepharospasm and
cervical dystonia across the two assessments showed
neither significant factor TIME (F = 0 04, p = 0 83) nor sig-
nificant GROUP×TIME interaction (F = 0 001, p = 0 97)
(Figure 1). Spearman’s correlation coefficient did not dis-
close any significant relationship between STDT values
and changes in disease severity scores.
4. Discussion
This is the first longitudinal study based on an 8-year follow-
up that has evaluated the STDT values during the course of
disease in patients with blepharospasm and cervical dystonia.
The novel finding of our study is that the abnormally
increased STDT values observed in patients with focal dysto-
nias remained unchanged whereas disease severity worsened
at the 8-year follow-up assessment.
We took several precautions to ensure that the data we
obtained were reliable. The neurophysiologist who tested
the patients’ STDT was blind to the clinical assessment, and
the investigators who performed the clinical assessment were
not informed of the purpose of the study. Since botulinum
toxin leaves STDT values unchanged in dystonic patients
[29], but is known to affect disease severity scores, the assess-
ments both upon enrolment and at follow-up were conducted
at least 4 months after the last botulinum toxin injection.
A recent study on the effect of aging on STDT measure-
ments showed that STDT values increases with aging [30].
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Figure 1: Somatosensory temporal discrimination threshold
(STDT) in healthy subjects and in patients with focal dystonias
(blepharospasm and cervical dystonia). (a) Mean STDT values
(expressed in milliseconds) in healthy subjects and patients with
dystonia (whole group). (b) Mean STDT values in patients with
blepharospasm and cervical dystonia tested upon enrolment and 8
years later. Bars represent standard deviation.
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When they investigated a large sample of healthy subjects,
Ramos et al. [30] found that the STDT increases by 0.66ms
every year in subjects older than 65 years. Therefore, the dys-
tonic patients who were aged 60 years upon enrolment and
68 years at the follow-up assessment may have been subject
to age-related changes in STDT values. However, our find-
ings are only apparently in contrast to this observation.
Indeed, if we bear in mind that the interstimulus interval dur-
ing STDT testing is increased in 10ms steps whereas the
STDT increases spontaneously by 0.66ms every year after
the age of 60 years, a 10-year age increase would yield a
6.6ms increase in STDT values. Thus, by increasing the
interstimulus interval during STDT testing in 10ms steps,
as we did, age-related increases in STDT values only start
having an effect well after 10 years.
Owing to the psychophysical nature of STDT testing,
an altered STDT in dystonia may be caused by behav-
ioural/attentional dysfunctions or psychiatric conditions,
both of which are known to occur in patients with dysto-
nia [5, 20, 31–33]. Since the STDT relies on the activity of
the basal ganglia combined with that of several cortical
areas, including the prefrontal areas, and since covert
attentional deficits or mood disorders may be responsible
for increased STDT values, we expected the dystonia
patients’ STDT values to change when tested at the
follow-up. Our findings showing that the STDT values
remained unmodified 8 years after the first assessment
contradict this hypothesis.
Previous studies on healthy subjects have demonstrated
that STDT values are modulated by plasticity mechanisms
in S1 induced by repetitive transcranial magnetic stimulation
at the cortical level [13, 22]. A recent study also showed that
high-frequency electrical stimulation of an area of skin on a
finger improves tactile temporal discrimination and that the
improvement is reversed within 24 hours [34]. The authors
of that study concluded that the perceptual effects on the
STDT they observed are likely to be dependent on plastic
changes in the somatosensory cortex, which is in accordance
with the concept that the timing of sensory stimuli is, at least
in part, encoded in the primary somatosensory cortex. In
keeping with this hypothesis, we have recently observed
[35] that the temporal discriminative acuity of tactile stimuli
is affected by the number of stimuli in the task and suggested
that stimulus-driven rapid plasticity is the main mechanism
underlying somatosensory temporal encoding in S1.
Investigating the neurophysiological correlates of abnor-
mal somatosensory temporal discrimination in dystonia,
Antelmi et al. [25] reported that STDT values were increased
in dystonic patients and were associated with reduced sup-
pression of cortical and subcortical paired-pulse somatosen-
sory evoked potentials as well as with a smaller area of the
high-frequency oscillation early component. Overall, these
findings point to a reduced activity in dystonic patients of
the inhibitory interneurons within the primary somatosen-
sory cortex although a possible contribution of altered inhib-
itory activity in the basal ganglia cannot be excluded.
Our observation that the STDT did not change either
in patients with blepharospasm or in those with cervical
dystonia, with or without clinical signs of spread, at the
follow-up assessment suggests that STDT abnormalities
in dystonia are representative of a background alteration in
inhibitory mechanisms. We hypothesize that this alteration
may be considered a “fingerprint” that remains stable over
time and is a predisposing factor of the disease. Since cortical
plasticity mechanisms rely on a dynamic balance between
excitatory and inhibitory interneurons [36, 37], it is conceiv-
able that altered inhibitory interneuron activity may concur
to give rise to other pathophysiological mechanisms in dysto-
nia, such as aberrant cortical plasticity mechanisms [3, 8].
Our findings showing that STDT values are unrelated to
the severity of motor disturbances and that they do not
change after 8 years despite the progression in dystonia
severity suggest that abnormal STDT is not a marker of
disease progression but is an endophenotypic marker of
the disease. On the same line, STDT changes are present
when dystonic features are not yet manifested in patients
with increased blinking, a condition now considered to
be a prodromal manifestation of blepharospasm [38, 39].
Different from dystonia in other basal ganglia conditions,
like Parkinson’s disease, STDT changes reflect dopaminergic
depletion [40, 41] and disease progression [42, 43].
A limitation of the present study may be the lack of a con-
trol group at follow-up. However, since STDT values in dys-
tonic patients were already altered at baseline and since
STDT values in dystonic patients remained unmodified at
follow-up, we believe that the lack of a control group at
follow-up unlikely affects the interpretation of our findings.
In conclusion, the results of our study showing that
STDT abnormalities in dystonia remain unmodified during
the course of the disease suggest that the abnormal activity
of inhibitory interneurons does not deteriorate further as
the disease progresses.
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